Kidney Disease Impacts Weight Loss After Bariatric Surgery
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Oct. 20, 2023 -- Early-stage chronic kidney disease has a negative impact on short-term weight loss outcomes after bariatric metabolic surgery, according to a study published online Oct. 10 in Obesity Surgery.
João Pereira, from the School of Medicine and Biomedical Sciences at the University of Porto in Portugal, and colleagues evaluated the impact of kidney dysfunction on weight loss outcomes after bariatric metabolic surgery. The analysis included 127 participants undergoing gastric bypass with preoperative evaluation, as well as assessment at six and 12 months after surgery.
The researchers found that after surgery, the mean body mass index was 27.7 kg/m2 at six months and 25.0 kg/m2 at 12 months versus 39.6 kg/m2 before surgery. In patients with a preoperative estimated glomerular filtration rate less than the 25th percentile, the percent of total weight loss was lower (34.4 versus 39.4 at 12 months). For preoperative creatinine clearance rate, proteinuria, or albuminuria, there were no significant correlations noted between weight loss metrics.
"These findings, if confirmed over longer period, suggest that patients with obesity and concomitant early-stage (G2) deterioration of kidney function can still achieve satisfactory weight loss outcomes after bariatric metabolic surgery, while potentially benefiting from renal function improvements as previously reported," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Risk for Kidney Complications Increased After Heart Failure Hospitalization
WEDNESDAY, June 5, 2024 -- Older adults with heart failure have considerable risk for kidney complications, with 6 percent progressing to dialysis at one year after...
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.